全文获取类型
收费全文 | 117070篇 |
免费 | 11663篇 |
国内免费 | 6397篇 |
专业分类
耳鼻咽喉 | 969篇 |
儿科学 | 1952篇 |
妇产科学 | 1514篇 |
基础医学 | 30360篇 |
口腔科学 | 3421篇 |
临床医学 | 8902篇 |
内科学 | 16634篇 |
皮肤病学 | 2129篇 |
神经病学 | 8908篇 |
特种医学 | 2359篇 |
外国民族医学 | 27篇 |
外科学 | 10090篇 |
综合类 | 17481篇 |
一般理论 | 2篇 |
预防医学 | 2948篇 |
眼科学 | 3168篇 |
药学 | 10946篇 |
19篇 | |
中国医学 | 3487篇 |
肿瘤学 | 9814篇 |
出版年
2024年 | 46篇 |
2023年 | 1377篇 |
2022年 | 1852篇 |
2021年 | 3288篇 |
2020年 | 3591篇 |
2019年 | 3137篇 |
2018年 | 3209篇 |
2017年 | 3864篇 |
2016年 | 4189篇 |
2015年 | 4737篇 |
2014年 | 7479篇 |
2013年 | 9059篇 |
2012年 | 7300篇 |
2011年 | 8585篇 |
2010年 | 7046篇 |
2009年 | 6734篇 |
2008年 | 6940篇 |
2007年 | 7000篇 |
2006年 | 6391篇 |
2005年 | 5507篇 |
2004年 | 4610篇 |
2003年 | 3779篇 |
2002年 | 2853篇 |
2001年 | 2394篇 |
2000年 | 2034篇 |
1999年 | 1635篇 |
1998年 | 1385篇 |
1997年 | 1288篇 |
1996年 | 1144篇 |
1995年 | 1352篇 |
1994年 | 1225篇 |
1993年 | 1058篇 |
1992年 | 867篇 |
1991年 | 818篇 |
1990年 | 714篇 |
1989年 | 694篇 |
1988年 | 600篇 |
1987年 | 537篇 |
1986年 | 471篇 |
1985年 | 726篇 |
1984年 | 637篇 |
1983年 | 442篇 |
1982年 | 578篇 |
1981年 | 445篇 |
1980年 | 392篇 |
1979年 | 328篇 |
1978年 | 218篇 |
1977年 | 171篇 |
1976年 | 165篇 |
1975年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Since their inception in the 1960s–70s, mesenchymal stem/stromal cells (MSCs) have gained interest because of their differentiation potential, anti-inflammatory effects, and immune-modulating properties. Both cell-based and cell-free MSC treatments show healing capacity in injured tissues. Cell-based treatment comprises MSCs and all secreted products, whereas cell-free treatments include only the secreted products. MSCs are therapeutically administered to many damaged organs owing to their efficacy. Specifically, the eye is a unique organ system to study the effects of MSCs, as treatment is easily applied and measured owing to its external location. The eye holds an immune-privileged status, wherein inflammation and immune responses are innately down-regulated. As excessive inflammation in the cornea often leads to fibrosis and irreversible corneal hazing, many studies have investigated the anti-inflammatory and immune-modulating capacities of MSCs. Decades of research suggest that MSCs modulate the immune response by secreting cytokines, growth factors, and extracellular matrix proteins that inhibit the infiltration of inflammatory cells following injury and promote a healing phenotype via M2 macrophage polarization. MSCs have also shown trans-differentiation potential into cornea-specific cell types during the wound healing process, such as corneal epithelial, stromal, or endothelial cells. This review discusses recent investigations of MSC treatment in the cornea, focusing on therapeutic efficacy, mechanisms, and future directions. 相似文献
3.
4.
Effect of Replacement of Wharton Acellular Jelly With FBS on the Expression of Megakaryocyte Linear Markers in Hematopoietic Stem Cells CD34+ 下载免费PDF全文
zahra Jalili Behnam Emamgolizadeh Hossein Abbaszadeh Shahla JaliliMehdi Derakhshani Mehdi YousefiMehdi TalebiKarim Shams Asenjan Ali Akabr Movassaghpour 《Asian Pacific journal of cancer prevention》2022,23(10):3281-3286
Objective: Animal environments for the growth of stem cells cause the transmission of some diseases and immune problems for the recipient. Accordingly, replacing these environments with healthy environments, at least with human resources, is essential. One of the media that can be used as an alternative to animal serums is Wharton acellular jelly (AWJ). Therefore, in this study, we intend to replace FBS with Wharton jelly and investigate its effect on the expression of megakaryocyte-related genes and markers in stem cells. Materials and Methods: In this study, cord blood-derived CD34 positive HSCs were cultured and expanded in the presence of cytokines including SCF, TPO, and FLT3-L. Then, the culture of expanded CD34 positive HSCs was performed in two groups: 1) IMDM culture medium containing 10% FBS and 100 ng / ml thrombopoietin cytokine 2) IMDM culture medium containing 10% AWJ, 100 ng / ml thrombopoietin cytokine. Finally, CD41 expressing cells were analyzed with the flow cytometry method. The genes related to megakaryocyte lineage including FLI1 and GATA2 were also evaluated using the RT-PCR technique. Results: The expression of CD41, a specific marker of megakaryocyte lineage in culture medium containing Wharton acellular jelly was increased compared to the FBS group. Additionally, the expression of GATA2 and FLI1 genes was significantly increased related to the control group. Conclusion: This study provided evidence of differentiation of CD34 positive hematopoietic stem cells from umbilical cord blood to megakaryocytes in a culture medium containing AWJ. 相似文献
5.
外泌体是一类直径为30~100 nm的圆盘囊泡,其内包含许多组分,诸如复杂RNA和蛋白质等,主要参与细胞间的信号转导。肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是肿瘤微环境中普遍存在的巨噬细胞,通过对肿瘤生长、免疫逃逸、侵袭和转移、耐药性等多方面的作用影响肿瘤进程。外泌体在肿瘤相关巨噬细胞的招募、极化及抗肿瘤免疫调控等方面发挥着重要的调节功能。同时,TAMs以外泌体为媒介作用于肿瘤细胞,从而构成了外泌体、TAMs与肿瘤细胞之间相互作用的调控通路。综上所述,本文旨在阐明肿瘤细胞与TAMs之间,以外泌体为“桥梁”相互影响的潜在机制,以及靶向肿瘤细胞和TAMs来源的外泌体在恶性肿瘤治疗中的展望。 相似文献
6.
7.
8.
9.
10.
《Transfusion and apheresis science》2022,61(6):103466
Transfusion related acute lung injury (TRALI) is a rare but potentially fatal pulmonary complication of transfusion that presents as acute hypoxemia and non-cardiogenic pulmonary oedema, developing during or within six hours of transfusion. Majority of the cases reported are due to transfusion of plasma rich blood components containing antibodies to human leukocyte antigen (anti-HLA) or human neutrophil antigen (anti-HNA). Rarely, anti-HLA or anti-HNA in recipients against transfused donor leukocyte antigens, cause TRALI by a reverse mechanism. Herein, we report three cases of suspected TRALI following transfusions of buffy coat derived granulocytes and peripheral blood stem cells. Three patients with hematological malignancies developed pulmonary symptoms after transfusions of leukocyte rich blood components. All cases showed findings of bilateral pulmonary infiltrates at chest radiography and patients were managed accordingly; however, all three expired within seven days of transfusion due to progressive respiratory deterioration. The patients were transfusion dependent for a long time and had received multiple non-leukoreduced blood components in the past. Clinical findings in all three cases indicate the possibility of reverse TRALI. Although, patients’ anti-HLA or anti-HNA antibodies concordance with donors’ cognate antigens (HLA and HNA) was not confirmed; yet these three cases suggest that reverse pathogenesis of TRALI is not as infrequent as reported in the literature. However, reverse TRALI has not been confirmed as the presence and nature of antibodies in the transfused recipient were not investigated due to the non availability of immunodiagnostic tests in India. 相似文献